Stay updated with the latest trade-expansion-act news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on trade-expansion-act topics.
New Delhi, Apr 3 (PTI) India is unlikely to be significantly impacted by US President Donald Trump's announcement of 100 per cent tariffs on certain patented drugs, as the country primarily exports low-cost generic medicines to America, think tank GTRI said on Friday. Trump signed an executive order on April 2, announcing the imposition of a 100 per cent ad valorem duty rate on the import of certain patented pharmaceuticals and associated pharmaceutical ingredients. The order, issued on April ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.